Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer-Reference-Cited by-同舟云学术

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer

Published:2019-01-27 Issue:2 Volume:124 Page:268-274
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Gupta Natasha¹,Bivalacqua Trinity J.¹,Han Misop¹,Gorin Michael A.¹^ORCID,Challacombe Ben J.²,Partin Alan W.¹,Mamawala Mufaddal K.¹^ORCID

Affiliation:

1. The James Buchanan Brady Urological Institute and Department of Urology; Johns Hopkins University School of Medicine; Baltimore MD USA

2. Department of Urology; Guy's and St. Thomas’ Hospitals NHS Foundation Trust; London UK

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14659/fullpdf

Reference27 articles.

1. Presurgery experiences of prostate cancer patients and their spouses;Gray;Cancer Pract,1999

2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer;Fowler;JAMA,2000

3. The patient's dilemma: prostate cancer treatment choices;Patel;J Urol,2003

4. Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote;Denberg;Cancer,2006

5. Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician?: results from a population-based study;Song;Cancer,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons For COVID-19 Era: Impact of Delays in Surgery on Biochemical Recurrence-Free Survival and Adverse Oncological Outcomes in Patients with Prostate Cancer;The Bulletin of Urooncology;2024-07-17

2. Is it safe to defer prostate cancer treatment? Assessing the impact of surgical delay on the risk of pathological upstaging after robot-assisted radical prostatectomy;European Journal of Surgical Oncology;2024-07

3. Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study;International Journal of Urology;2024-04-30

4. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations;Urologic Oncology: Seminars and Original Investigations;2023-05

5. Increasing surgical wait time does not increase the risk of node positive prostate cancer: Implications for surgical planning during the COVID-19 pandemic and beyond;Frontiers in Urology;2023-03-09